金沢大学がん研究所がん分子細胞制御A Japanese family with atypical type I familial amyloidotic polyneuropathy (FAP) in Iiyama, Japan, was studied. Most of the family members have dysfunctions of the central nervous system, in addition to typical symptoms of type I FAP. The transthyretin (TTR, also called prealbumin) gene of the atypical FAP (FAP-IY) was analyzed with recombinant DNA techniques and a RIA method. FAP-IY was found to have the mutation responsible for the methionine-for-valine substitution at position 30 of TTR, as in the case of typical type I FAP. However, analysis of DNA polymorphisms in the TTR locus showed that FAP-IY has a genetic background differing from that of the typical type I FAP. These observations lead to the consideration that a ...
AbstractA novel variant transthyretin which contains a leucine-for-valine substitution at position 3...
Background. Transthyretin-related familial amyloid polyneuropathy (ATTR-FAP) is a rare, progressive,...
International audienceObjective To compare the natural history of familial transthyretin amyloid pol...
A Japanese family with atypical type I familial amyloidotic polyneuropathy (FAP) in Iiyama, Japan wa...
Familial amyloidotic polyneuropathy type 1 (FAP1, MIM176300) is an autosomal dominant disease caused...
AbstractWe report the molecular analysis of the transthyretin gene in a large Italian pedigree with ...
To report the clinical, pathologic and molecular genetic features of a Chinese family with familial ...
Familial amyloid polyneuropathy (FAP) is a rare condition caused by mutations of the transthyretin (...
As part of an epidemiological study that aims to characterize chemically the mutation(s) in transthy...
金沢大学医学部附属病院神経内科A family with familial amyloid polyneuropathy (FAP) due to a transthyretin (TTR) Leu5...
Familial amyloid polyneuropathy (FAP) is a progressive systemic autosomal dominant disease caused by...
The authors reviewed contribution of Kumamoto University group to the progress of the studies on tra...
Background. Familial Amyloidosis with Polyneuropathy (FAP) is an autosomal dominantly inherited syst...
Familial amyloid polyneuropathy (FAP) is rare and most commonly caused by the Val30Met mutation of t...
PubMed ID: 27238058Transthyretin-related familial amyloid polyneuropathy (TTR-FAP) is an autosomal d...
AbstractA novel variant transthyretin which contains a leucine-for-valine substitution at position 3...
Background. Transthyretin-related familial amyloid polyneuropathy (ATTR-FAP) is a rare, progressive,...
International audienceObjective To compare the natural history of familial transthyretin amyloid pol...
A Japanese family with atypical type I familial amyloidotic polyneuropathy (FAP) in Iiyama, Japan wa...
Familial amyloidotic polyneuropathy type 1 (FAP1, MIM176300) is an autosomal dominant disease caused...
AbstractWe report the molecular analysis of the transthyretin gene in a large Italian pedigree with ...
To report the clinical, pathologic and molecular genetic features of a Chinese family with familial ...
Familial amyloid polyneuropathy (FAP) is a rare condition caused by mutations of the transthyretin (...
As part of an epidemiological study that aims to characterize chemically the mutation(s) in transthy...
金沢大学医学部附属病院神経内科A family with familial amyloid polyneuropathy (FAP) due to a transthyretin (TTR) Leu5...
Familial amyloid polyneuropathy (FAP) is a progressive systemic autosomal dominant disease caused by...
The authors reviewed contribution of Kumamoto University group to the progress of the studies on tra...
Background. Familial Amyloidosis with Polyneuropathy (FAP) is an autosomal dominantly inherited syst...
Familial amyloid polyneuropathy (FAP) is rare and most commonly caused by the Val30Met mutation of t...
PubMed ID: 27238058Transthyretin-related familial amyloid polyneuropathy (TTR-FAP) is an autosomal d...
AbstractA novel variant transthyretin which contains a leucine-for-valine substitution at position 3...
Background. Transthyretin-related familial amyloid polyneuropathy (ATTR-FAP) is a rare, progressive,...
International audienceObjective To compare the natural history of familial transthyretin amyloid pol...